SCHEMBL30211665

SCHEMBL30211665

[2H]C1([2H])C(=O)C(C(=O)OCC)CCN1Cc1ccc(OC)cc1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 6/20 0.51
MAPT P10636 1/20 0.51
POLB P06746 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
KMT2A Q03164 4/20 0.46
SIGMAR1 Q99720 1/20 0.46
MEN1 O00255 3/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24355064 0.90 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL30211662 0.86 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL6988354 0.81 KDM4E (0.74) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL16903450 0.81 KDM4E (0.47) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL9831746 0.80 KDM4E (0.48) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL30323391 0.80 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL30211679 0.80 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL184071 0.76 MEN1 (0.56) ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A
SCHEMBL1622710 0.75 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL184070 0.75 MEN1 (0.55) ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4153549-A2 RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Certego Therapeutics Inc. (US) 2023-03-29 EP disclosed